Anticancer Research · 2018 · 15 citations · 10 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyNeoplasiaApoptosis ResistanceCancer Cell SignalingCancer Molecular PathologyLung CancerMalignant NeoplasmsPharmacodynamics Of Anticancer AgentsAnti-apoptotic ProteinsAnticancer ActivityApoptotic Signaling PathwaysCell InvasionNf-kappa B-mediated Anti-apoptotic SignalingNf-κb SignalingNon-small Cell Lung Cancer TreatmentNuclear Factor Kappa B Signaling
BACKGROUND/AIM: Previous studies have indicated that hyperforin inhibits tumor growth of hepatocellular carcinoma. However, the anticancer effects of hyperforin in non-small cell lung cancer (NSCLC) are ambiguous. The aim of the present study was to investigate the anticancer effect of hyperforin in NSCLC. NSCLC CL1-5-F4 cells were treated with different concentrations of hyperforin or NF-κB inhibitor (QNZ) for different time periods. MATERIALS AND METHODS: Change of cell viability, NF-κB activation, apoptotic signaling pathways, expression of anti-apoptotic proteins, and cell invasion were detected using the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, NF-κB reporter gene assay, flow cytometry, western blotting, and cell invasion assay. RESULTS: The results demonstrated that hyperforin significantly promotes extrinsic and intrinsic apoptotic pathways, and inhibits cell viability and NF-κB activation. In addition, results also indicated that blockage of NF-κB activation reduces the levels of anti-apoptotic proteins and cell invasion in CL1-5-F4 cells. CONCLUSION: These results suggested hyperforin induces apoptosis and inhibits NF-κB-modulated anti-apoptotic and invasive potential in NSCLC.
10
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina, Ping Yang, Stephen D. Cassivi et al. · Mayo Clinic Proceedings · 2008 · 2.9K citations
Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
Haiying Zhang, Sudha R. Guttikonda, Lisa Roberts et al. · Oncogene · 2010 · 161 citations
Medicine, Cell Biology, Oncology +12
Hyperforin Inhibits Cancer Invasion and Metastasis
Massimo Donà, Isabella Dell’Aica, Elga Pezzato et al. · Cancer Research · 2004 · 137 citations
Medicine, Oncology, Pharmacology +17